50.36
전일 마감가:
$48.47
열려 있는:
$49.07
하루 거래량:
4.79M
Relative Volume:
1.94
시가총액:
$6.48B
수익:
$10.12M
순이익/손실:
$-280.49M
주가수익비율:
-17.43
EPS:
-2.89
순현금흐름:
$-188.51M
1주 성능:
+8.12%
1개월 성능:
+31.63%
6개월 성능:
+70.42%
1년 성능:
+23.55%
어비디티 바이오사이언스 Stock (RNA) Company Profile
명칭
Avidity Biosciences Inc
전화
858-401-7900
주소
10578 SCIENCE CENTER DRIVE, SAN DIEGO, CA
RNA을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
RNA
Avidity Biosciences Inc
|
50.36 | 6.24B | 10.12M | -280.49M | -188.51M | -2.89 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
어비디티 바이오사이언스 Stock (RNA) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-07-10 | 재개 | Goldman | Buy |
2025-06-24 | 개시 | Bernstein | Outperform |
2025-06-17 | 개시 | Wolfe Research | Outperform |
2025-06-11 | 개시 | Raymond James | Strong Buy |
2025-03-13 | 개시 | Citigroup | Buy |
2025-03-12 | 개시 | BMO Capital Markets | Outperform |
2025-03-07 | 개시 | Scotiabank | Sector Outperform |
2024-12-20 | 개시 | H.C. Wainwright | Buy |
2024-11-26 | 개시 | RBC Capital Mkts | Outperform |
2024-09-24 | 개시 | Goldman | Buy |
2024-08-28 | 개시 | Barclays | Overweight |
2024-05-03 | 개시 | BofA Securities | Buy |
2024-03-14 | 개시 | Cantor Fitzgerald | Overweight |
2023-05-22 | 업그레이드 | Evercore ISI | In-line → Outperform |
2023-03-31 | 다운그레이드 | Evercore ISI | Outperform → In-line |
2022-07-20 | 개시 | Chardan Capital Markets | Buy |
2022-07-12 | 개시 | Raymond James | Strong Buy |
2021-09-07 | 개시 | Evercore ISI | Outperform |
2021-06-17 | 개시 | Needham | Buy |
2021-04-26 | 재개 | Credit Suisse | Outperform |
2020-07-07 | 개시 | Cowen | Outperform |
2020-07-07 | 개시 | Credit Suisse | Outperform |
2020-07-07 | 개시 | SVB Leerink | Outperform |
2020-07-07 | 개시 | Wells Fargo | Overweight |
모두보기
어비디티 바이오사이언스 주식(RNA)의 최신 뉴스
Is Avidity Biosciences Inc. stock ready for a breakoutJuly 2025 Summary & Daily Price Action Insights - Newser
Should you avoid Avidity Biosciences Inc. stock right nowJuly 2025 Earnings & Precise Swing Trade Alerts - خودرو بانک
Sentiment analysis tools applied to Avidity Biosciences IncCEO Change & Free AI Powered Buy and Sell Recommendations - Newser
Volume spikes in Avidity Biosciences Inc. stock – what they meanMarket Movers & Safe Entry Point Alerts - Newser
Can Avidity Biosciences Inc. recover in the next quarterWeekly Investment Recap & AI Based Buy and Sell Signals - Newser
Avidity Biosciences shares rise 3.80% intraday after presenting at Cantor Global and Wells Fargo conferences. - AInvest
Take Profit: Can Avidity Biosciences Inc. outperform under higher oil pricesMarket Activity Report & Expert Verified Stock Movement Alerts - خودرو بانک
Avidity Biosciences: Pioneering RNA Therapeutics in the Race for Rare Disease Leadership - AInvest
Avidity Biosciences: Pioneering Precision in Gene Therapy with AOC Platform - AInvest
Transcript : Avidity Biosciences, Inc. Presents at Wells Fargo 20th Annual Healthcare Conference 2025, Sep-04-2025 12 - MarketScreener
Using Python tools to backtest Avidity Biosciences Inc. strategies2025 Key Lessons & AI Driven Price Predictions - Newser
Is Avidity Biosciences Inc. a top pick in the sector2025 Historical Comparison & Risk Managed Investment Entry Signals - خودرو بانک
Full technical analysis of Avidity Biosciences Inc. stockMarket Trend Summary & Consistent Income Trade Ideas - Newser
Is now a turning point for Avidity Biosciences Inc.Weekly Profit Report & Proven Capital Preservation Methods - Newser
Avidity Biosciences Inc. stock trend forecastJuly 2025 PostEarnings & Community Verified Trade Signals - Newser
Technical Heatmap Flags Avidity Biosciences Inc. for WatchJuly 2025 Sector Moves & Community Verified Swing Trade Signals - beatles.ru
What’s the RSI of Avidity Biosciences Inc. stockJuly 2025 Technicals & Technical Entry and Exit Tips - خودرو بانک
Avidity Biosciences Inc. stock momentum explainedWeekly Profit Analysis & Technical Confirmation Alerts - Newser
Is Avidity Biosciences Inc. forming a reversal patternQuarterly Performance Summary & Accurate Trade Setup Notifications - Newser
News impact scoring models applied to Avidity Biosciences Inc.Analyst Downgrade & Risk Controlled Daily Plans - Newser
Price momentum metrics for Avidity Biosciences Inc. explainedJuly 2025 Update & Weekly Stock Breakout Alerts - Newser
Technical analysis overview for Avidity Biosciences Inc. stockWeekly Investment Summary & Low Risk High Reward Trade Ideas - Newser
Order flow analysis tools used on Avidity Biosciences Inc.July 2025 Setups & High Conviction Investment Ideas - Newser
Tools to monitor Avidity Biosciences Inc. recovery probabilityTrade Risk Assessment & Advanced Swing Trade Entry Plans - Newser
Avidity Biosciences CPO sells $8914 in RNA stock By Investing.com - Investing.com South Africa
Avidity Biosciences CPO sells $8914 in RNA stock - Investing.com
Avidity Biosciences' Kathleen Gallagher Sells 188 Shares at $47.42 - AInvest
Arrowhead, Novartis in up to $2 billion deal for neuromuscular therapy license - Reuters
Is Avidity Biosciences Inc. stock showing strong momentumJuly 2025 Outlook & Capital Efficiency Focused Strategies - خودرو بانک
Reversal indicators forming on Avidity Biosciences Inc. stockEarnings Beat & Free Weekly Watchlist of Top Performers - Newser
Detecting price anomalies in Avidity Biosciences Inc. with AIEarnings Recap Report & Weekly High Conviction Ideas - Newser
Can Avidity Biosciences Inc. outperform under higher oil pricesJuly 2025 News Drivers & Expert Approved Trade Ideas - خودرو بانک
How to use a screener to detect Avidity Biosciences Inc. breakouts2025 Bull vs Bear & High Return Trade Opportunity Guides - Newser
Momentum Shift: Can Avidity Biosciences Inc. reach resistance levels soonQuarterly Profit Summary & Reliable Price Breakout Alerts - خودرو بانک
Short Covering: Is Avidity Biosciences Inc. stock a top performer YTD2025 Price Momentum & AI Powered Trade Plan Recommendations - خودرو بانک
Analyzing recovery setups for Avidity Biosciences Inc. investorsPortfolio Value Summary & Stepwise Trade Execution Plans - Newser
Published on: 2025-09-02 00:27:58 - خودرو بانک
Is Avidity Biosciences Inc. a potential multi baggerJuly 2025 Institutional & Stepwise Trade Execution Plans - خودرو بانک
RNA Stock Price and Chart — NASDAQ:RNA - TradingView
What moving averages say about Avidity Biosciences Inc.July 2025 Trade Ideas & Free Risk Controlled Daily Trade Plans - Newser
Does Avidity Biosciences Inc. show high probability of reboundWeekly Trend Summary & Safe Entry Point Alerts - Newser
Published on: 2025-08-31 20:59:49 - Newser
Risk vs reward if holding onto Avidity Biosciences Inc.Quarterly Profit Report & Expert Approved Momentum Ideas - Newser
Is Avidity Biosciences Inc.’s ROE strong enough2025 Key Lessons & Expert-Curated Trade Recommendations - sundaytimes.kr
어비디티 바이오사이언스 (RNA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
어비디티 바이오사이언스 주식 (RNA) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Boyce Sarah | President and CEO |
Sep 05 '25 |
Sale |
49.95 |
50,000 |
2,497,435 |
305,871 |
Mosbrooker Eric | Chief Commercial Officer |
Sep 03 '25 |
Option Exercise |
9.05 |
6,563 |
59,395 |
61,563 |
Mosbrooker Eric | Chief Commercial Officer |
Sep 03 '25 |
Sale |
47.07 |
6,563 |
308,936 |
55,000 |
자본화:
|
볼륨(24시간):